172 related articles for article (PubMed ID: 36513449)
21. Marked individual variation in isoflavone metabolism after a soy challenge can modulate the skeletal effect of isoflavones in premenopausal women.
Kwak HS; Park SY; Kim MG; Yim CH; Yoon HK; Han KO
J Korean Med Sci; 2009 Oct; 24(5):867-73. PubMed ID: 19794985
[TBL] [Abstract][Full Text] [Related]
22. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods.
Cassidy A; Brown JE; Hawdon A; Faughnan MS; King LJ; Millward J; Zimmer-Nechemias L; Wolfe B; Setchell KD
J Nutr; 2006 Jan; 136(1):45-51. PubMed ID: 16365057
[TBL] [Abstract][Full Text] [Related]
23. Effect of whole soy and purified isoflavone daidzein on renal function--a 6-month randomized controlled trial in equol-producing postmenopausal women with prehypertension.
Liu ZM; Ho SC; Chen YM; Tang N; Woo J
Clin Biochem; 2014 Sep; 47(13-14):1250-6. PubMed ID: 24877660
[TBL] [Abstract][Full Text] [Related]
24. Soy isoflavone intake and estrogen excretion patterns in young women: effect of probiotic administration.
Cohen LA; Crespin JS; Wolper C; Zang EA; Pittman B; Zhao Z; Holt PR
In Vivo; 2007; 21(3):507-12. PubMed ID: 17591361
[TBL] [Abstract][Full Text] [Related]
25. Effect of whole soy and isoflavones daidzein on bone turnover and inflammatory markers: a 6-month double-blind, randomized controlled trial in Chinese postmenopausal women who are equol producers.
Liu ZM; Chen B; Li S; Li G; Zhang D; Ho SC; Chen YM; Ma J; Qi H; Ling WH
Ther Adv Endocrinol Metab; 2020; 11():2042018820920555. PubMed ID: 32595918
[TBL] [Abstract][Full Text] [Related]
26. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women.
Petrakis NL; Barnes S; King EB; Lowenstein J; Wiencke J; Lee MM; Miike R; Kirk M; Coward L
Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):785-94. PubMed ID: 8896889
[TBL] [Abstract][Full Text] [Related]
27. Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population.
Maskarinec G; Singh S; Meng L; Franke AA
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):613-9. PubMed ID: 9681530
[TBL] [Abstract][Full Text] [Related]
28. Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: a double-blind, randomized, placebo-controlled crossover trial in postmenopausal women.
van der Velpen V; Geelen A; Hollman PC; Schouten EG; van 't Veer P; Afman LA
Am J Clin Nutr; 2014 Nov; 100(5):1269-77. PubMed ID: 25332325
[TBL] [Abstract][Full Text] [Related]
29. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.
Gardner CD; Oelrich B; Liu JP; Feldman D; Franke AA; Brooks JD
Prostate; 2009 May; 69(7):719-26. PubMed ID: 19180569
[TBL] [Abstract][Full Text] [Related]
30. A randomized isoflavone intervention among premenopausal women.
Maskarinec G; Williams AE; Inouye JS; Stanczyk FZ; Franke AA
Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):195-201. PubMed ID: 11867507
[TBL] [Abstract][Full Text] [Related]
31. Various doses of soy isoflavones do not modify mammographic density in postmenopausal women.
Maskarinec G; Verheus M; Steinberg FM; Amato P; Cramer MK; Lewis RD; Murray MJ; Young RL; Wong WW
J Nutr; 2009 May; 139(5):981-6. PubMed ID: 19321587
[TBL] [Abstract][Full Text] [Related]
32. Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County.
Wu AH; Yu MC; Tseng CC; Twaddle NC; Doerge DR
Carcinogenesis; 2004 Jan; 25(1):77-81. PubMed ID: 14555615
[TBL] [Abstract][Full Text] [Related]
33. Soy for breast cancer survivors: a critical review of the literature.
Messina MJ; Loprinzi CL
J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
[TBL] [Abstract][Full Text] [Related]
34. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165].
Atkinson C; Warren RM; Sala E; Dowsett M; Dunning AM; Healey CS; Runswick S; Day NE; Bingham SA
Breast Cancer Res; 2004; 6(3):R170-9. PubMed ID: 15084240
[TBL] [Abstract][Full Text] [Related]
35. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women.
Steinberg FM; Murray MJ; Lewis RD; Cramer MA; Amato P; Young RL; Barnes S; Konzelmann KL; Fischer JG; Ellis KJ; Shypailo RJ; Fraley JK; Smith EO; Wong WW
Am J Clin Nutr; 2011 Feb; 93(2):356-67. PubMed ID: 21177797
[TBL] [Abstract][Full Text] [Related]
37. A six-month randomized controlled trial of whole soy and isoflavones daidzein on body composition in equol-producing postmenopausal women with prehypertension.
Liu ZM; Ho SC; Chen YM; Woo J
J Obes; 2013; 2013():359763. PubMed ID: 23984051
[TBL] [Abstract][Full Text] [Related]
38. Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk.
Setchell KD; Brown NM; Zhao X; Lindley SL; Heubi JE; King EC; Messina MJ
Am J Clin Nutr; 2011 Nov; 94(5):1284-94. PubMed ID: 21955647
[TBL] [Abstract][Full Text] [Related]
39. Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial.
Henderson VW; St John JA; Hodis HN; Kono N; McCleary CA; Franke AA; Mack WJ;
Neurology; 2012 Jun; 78(23):1841-8. PubMed ID: 22665144
[TBL] [Abstract][Full Text] [Related]
40. Fecal bacterial community changes associated with isoflavone metabolites in postmenopausal women after soy bar consumption.
Nakatsu CH; Armstrong A; Clavijo AP; Martin BR; Barnes S; Weaver CM
PLoS One; 2014; 9(10):e108924. PubMed ID: 25271941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
